Remodeling dendritic spines for treatment of traumatic brain injury

被引:0
作者
Ye Xiong [1 ]
Asim Mahmood [1 ]
Michael Chopp [2 ,3 ]
机构
[1] Department of Neurosurgery, Henry Ford Hospital
[2] Department of Neurology, Henry Ford Hospital
[3] Department of Physics, Oakland University
关键词
traumatic brain injury; dendritic spines; synaptic plasticity; spinogenic agents; treatment; spine remodeling; memory; functional recovery;
D O I
暂无
中图分类号
R651.15 [];
学科分类号
1002 ; 100210 ;
摘要
Traumatic brain injury is an important global public health problem. Traumatic brain injury not only causes neural cell death, but also induces dendritic spine degeneration. Spared neurons from cell death in the injured brain may exhibit dendrite damage, dendritic spine degeneration, mature spine loss, synapse loss, and impairment of activity. Dendritic degeneration and synapse loss may significantly contribute to functional impairments and neurological disorders following traumatic brain injury. Normal function of the nervous system depends on maintenance of the functionally intact synaptic connections between the presynaptic and postsynaptic spines from neurons and their target cells. During synaptic plasticity, the numbers and shapes of dendritic spines undergo dynamic reorganization. Enlargement of spine heads and the formation and stabilization of new spines are associated with long-term potentiation, while spine shrinkage and retraction are associated with long-term depression. Consolidation of memory is associated with remodeling and growth of preexisting synapses and the formation of new synapses. To date,there is no effective treatment to prevent dendritic degeneration and synapse loss. This review outlines the current data related to treatments targeting dendritic spines that propose to enhance spine remodeling and improve functional recovery after traumatic brain injury. The mechanisms underlying proposed beneficial effects of therapy targeting dendritic spines remain elusive, possibly including blocking activation of Cofilin induced by beta amyloid, Ras activation, and inhibition of GSK-3 signaling pathway. Further understanding of the molecular and cellular mechanisms underlying synaptic degeneration/loss following traumatic brain injury will advance the understanding of the pathophysiology induced by traumatic brain injury and may lead to the development of novel treatments for traumatic brain injury.
引用
收藏
页码:1477 / 1480
页数:4
相关论文
共 50 条
  • [31] Treatment of Traumatic Brain Injury with Vepoloxamer (Purified Poloxamer 188)
    Zhang, Yanlu
    Chopp, Michael
    Emanuele, Martin
    Zhang, Li
    Zhang, Zheng Gang
    Lu, Mei
    Zhang, Talan
    Mahmood, Asim
    Xiong, Ye
    JOURNAL OF NEUROTRAUMA, 2018, 35 (04) : 661 - 670
  • [32] Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors
    Galgano, Michael
    Toshkezi, Gentian
    Qiu, Xuecheng
    Russell, Thomas
    Chin, Lawrence
    Zhao, Li-Ru
    CELL TRANSPLANTATION, 2017, 26 (07) : 1118 - 1130
  • [33] Stem Cells and Bioactive Scaffolds as a Treatment for Traumatic Brain Injury
    Stabenfeldt, Sarah E.
    Irons, Hillary R.
    LaPlaca, Michelle C.
    CURRENT STEM CELL RESEARCH & THERAPY, 2011, 6 (03) : 208 - 220
  • [34] Discourse-based treatment in mild traumatic brain injury
    Kintz, Stephen
    Hibbs, Valentyna
    Henderson, Amy
    Andrews, Morgan
    Wright, Heather Harris
    JOURNAL OF COMMUNICATION DISORDERS, 2018, 76 : 47 - 59
  • [35] Cognitive Rehabilitation Following Traumatic Brain Injury: Assessment to Treatment
    Tsaousides, Theodore
    Gordon, Wayne A.
    MOUNT SINAI JOURNAL OF MEDICINE, 2009, 76 (02): : 173 - 181
  • [36] Stem cells and combination therapy for the treatment of traumatic brain injury
    Dekmak, AmiraSan
    Mantash, Sarah
    Shaito, Abdullah
    Toutonji, Amer
    Ramadan, Naify
    Ghazale, Hussein
    Kassem, Nouhad
    Darwish, Hala
    Zibara, Kazem
    BEHAVIOURAL BRAIN RESEARCH, 2018, 340 : 49 - 62
  • [37] Pathophysiology and Treatment of Memory Dysfunction After Traumatic Brain Injury
    Paterno, Rosalia
    Folweiler, Kaitlin A.
    Cohen, Akiva S.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (07)
  • [38] Peptidergic drugs for the treatment of traumatic brain injury
    Alvarez, X. Anton
    Figueroa, Jesus
    Muresanu, Dafin
    FUTURE NEUROLOGY, 2013, 8 (02) : 175 - 192
  • [39] Treatment of depression following traumatic brain injury
    Alderfer, BS
    Arciniegas, DB
    Silver, JM
    JOURNAL OF HEAD TRAUMA REHABILITATION, 2005, 20 (06) : 544 - 562
  • [40] Drug Repurposing in the Treatment of Traumatic Brain Injury
    Ghiam, Michael K.
    Patel, Shrey D.
    Hoffer, Alan
    Selman, Warren R.
    Hoffer, Barry J.
    Hoffer, Michael E.
    FRONTIERS IN NEUROSCIENCE, 2021, 15